Navigation Links
Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California
Date:9/20/2011

o fund acquisitions and developments, and the ability to refinance indebtedness as it comes due; failure to maintain the company's investment grade credit ratings with the ratings agencies; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; reductions in asset valuations and related impairment charges; risks and uncertainties affecting property development and construction; risks associated with downturns in the national and local economies, increases in interest rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Isis Forward Looking Statement

This press release includes forward-looking statements regarding Isis Pharmaceuticals' business, and the therapeutic and commercial potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of mipomersen, is a forward-looking statement and should be considered
'/>"/>

SOURCE BioMed Realty Trust, Inc.; Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Eli Lilly and Company (NYSE: ... was statistically superior to placebo in the treatment of ... the proportion of patients achieving an ACR 20 response. ... 20 percent reduction in disease signs and symptoms as ... During the 24-week, Phase 3 study, titled SPIRIT-P1, patients ...
(Date:4/20/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... GTC Diabetes Summit, in the 8 th Diabetes ... 2015 in Boston . Dr. ... a session titled "Early Clinical Impressions of Oral Insulin ...
(Date:4/20/2015)... 20, 2015  ULURU Inc. (OTCQB: ULUR) announced ... with Inter-Mountain Capital Corporation ("Inter-Mountain") to resolve the ... Under the terms of the settlement, ... issued an unsecured Promissory Note for $550,000, and ... of Common Stock at an exercise price of ...
Breaking Medicine Technology:Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4Oramed to Present at the GTC Diabetes Summit 2Oramed to Present at the GTC Diabetes Summit 3ULURU Inc. Announces the Settlement of Outstanding Litigation 2
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has ... Foundation for Parkinson,s Research (MJFF) to support studies in non-human primates for ... $900,000 award will be paid over a period of two ... Sangamo has ...
... July 1 Watson Pharmaceuticals, Inc. (NYSE: ... settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis ... "Novartis"), Watson has commenced shipment of a generic version ... capsules.  Exelon® is used to treat dementia (a brain ...
Cached Medicine Technology:Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 2Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 3Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 4Watson Launches Generic Exelon® 2Watson Launches Generic Exelon® 3
(Date:4/20/2015)... Burlington, Vt. (PRWEB) April 20, 2015 ... environmental networks, is excited to announce that Kate Williams, the ... CEO, effective May 1, 2015. , Williams has been part ... nearly decade-long tenure as Executive Director of the Northern Forest ... Williams has dedicated her career to the stewardship of and ...
(Date:4/20/2015)... 2015 Today the members of ... Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Translational ... will focus on “DNA Repair Therapies for Ovarian ... DNA repair as a common weakness in ovarian ... early detection of ovarian cancer by developing a ...
(Date:4/20/2015)... Grateful Dead originally formed in 1965 ... 1995. The group was more than just about rock music. ... space rock, country, and other genres to put together their ... The group was inducted into the Rock and Roll Hall ... than 35 million records worldwide. This year marks the ...
(Date:4/20/2015)... Westchester County, New York (PRWEB) April 20, 2015 ... that the Centers for Medicare & Medicaid Services introduced ... of their HCAHPS (Hospital Consumer Assessment of Healthcare Providers ... This national survey asks patients about their experiences during ... current survey results from July 1, 2013 through June ...
(Date:4/20/2015)... Insuranceautoquote.info has released a new blog post ... online . , Affordable auto insurance quotes can ... should always compare online car insurance rates in their ... website: . http://insuranceautoquote.info , The process is ... in a few minutes and the search engine offers ...
Breaking Medicine News(10 mins):Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Affordable Auto Insurance Quotes Can Be Found Online, Fast and Easy 2
... Blue Distinction Centers,for Complex and Rare Cancers(SM), CHICAGO, ... the overall quality of healthcare in America, Blue Cross ... Today, Blue Cross and Blue Shield members have ... Complex and Rare Cancers across 33,states. With this expansion, ...
... Inc. (Nasdaq: ALXN ) today announced that Leonard ... at,two upcoming investor conferences, one sponsored by Cowen and ... will present at the Cowen and Company 27th Annual ... Tuesday, March 18, 2008.,Dr. Bell will also present at ...
... Granite State Manufacturing (GSM),a New Hampshire-based ... acquired Scandia Manufacturing Company Inc. (Scandia),a leading ... systems,for the Department of Defense. The acquisition ... States Navy., Granite State Manufacturing plans ...
... March 11 Pepperdine,University,s Graziadio School of ... to a MBA business plan addressing California,s ... Mara Kamins, Nurse,Education Web, a web-based clinical ... place in the Pepperdine University Fourth Annual,Business ...
... Education at ... ... 11 ,GetWellNetwork, Inc., a leading provider of Interactive Patient Care ... today announced a partnership to co-develop a comprehensive,suite of pediatric ...
... 11 EaglePicher,Medical Power, a leading supplier of ... that Joseph (Joe) Marotta has,joined the company as ... this position, Mr. Marotta will be responsible for ... including customer,development initiatives. EaglePicher,s medical division has seen ...
Cached Medicine News:Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 2Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 3Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 4Health News:Granite State Manufacturing Acquires Scandia Manufacturing Company Inc. 2Health News:Pepperdine Business Plan Competition Awards $26,000 to MBA Teams 2Health News:Pepperdine Business Plan Competition Awards $26,000 to MBA Teams 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 4Health News:EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing 2
... The Titan™ Inflatable Penile ... system designed to be surgically ... the management of erectile dysfunction ... implant provides the patient with ...
... The Alpha I continues to be a ... the Alpha I to have mechanical reliability ... on first-time implants. ioflex material contributes to ... I. Thats because Bioflex: ,Provides maximum, controlled ...
... advanced three-part inflatable prosthesis consisting of a reservoir ... the scrotum and a pair of cylinders inserted ... look and performance of a natural erection. The ... AMS 700 Series now features the new Tactile ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: